Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 10 Recurrence 1 Pathologic Complete Response 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1 Colitis, Ischemic 1 Coitus 1

Interventions

Oxaliplatin 14 Fluorouracil 11 Capecitabine 9 Surveys and Questionnaires 8 Leucovorin 8 Irinotecan 8 Cisplatin 8 Bevacizumab 8 Standard of Care 5 Gemcitabine 5 Drug Therapy 4 S 1 (combination) 3 Radiotherapy 3 Nivolumab 3 Interviews as Topic 3 IFL protocol 3 Educational Status 3 Cyclophosphamide 3 Colonoscopy 3 Blood Specimen Collection 3 5,10-methylenetetrahydrofolic acid 3 trebananib 2 tivozanib 2 pembrolizumab 2 Taxes 2 Remote Patient Monitoring 2 Pemetrexed 2 Panitumumab 2 Ocoxin 2 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gastrointestinal Neoplasms × Proctectomy × Clear all

NCT07017712 2025-06-12

SeDiGCS

Medizinische Hochschule Brandenburg Theodor Fontane

870,754 enrolled

Gastrointestinal

Coitus, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡